Albemarle Corporation Company Profile (NYSE:ALB)

Albemarle Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle Corporation announced a quarterly dividend on Monday, July 10th. Stockholders of record on Friday, September 15th will be paid a dividend of $0.32 per share on Monday, October 2nd. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend is Thursday, September 14th. View Albemarle Corporation's Dividend History.

Albemarle Corporation (NYSE:ALB) issued its earnings results on Monday, August, 7th. The company reported $1.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.02. The company had revenue of $737.25 million for the quarter, compared to analyst estimates of $735.50 million. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.93 earnings per share. View Albemarle Corporation's Earnings History.

Albemarle Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Albemarle Corporation.

Albemarle Corporation updated its FY17 earnings guidance on Monday, August, 7th. The company provided EPS guidance of $4.20-4.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.36. The company issued revenue guidance of $2.90-3.05 billion, compared to the consensus revenue estimate of $2.95 billion.

16 analysts have issued 12-month price targets for Albemarle Corporation's stock. Their predictions range from $36.00 to $156.00. On average, they anticipate Albemarle Corporation's stock price to reach $113.06 in the next twelve months. View Analyst Ratings for Albemarle Corporation.

Here are some recent quotes from research analysts about Albemarle Corporation stock:

• 1. According to Zacks Investment Research, "Albemarle has outperformed the industry it belongs to over a year.  Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong expected growth in the battery-grade lithium market. The company should also gain from the synergies of Rockwood Holdings acquisition. Albemarle is also divesting non-core assets to boost growth opportunities and focus on its key businesses. Moreover, the company remains committed to deliver incremental returns to shareholders, leveraging healthy cash flows. However, Albemarle faces headwinds associated with higher expected operational costs and higher tax rate in 2017. The company’s stretched valuation is another concern." (8/1/2017)
• 2. UBS AG analysts commented, "Theme was 'potential 'drives everything ALB does'. Batteries store potential energy chemically, until needed to create electrical potential to power devices. Lithium chem. is the primary driver of ALB earnings growth. 2021 targets were introduced for 7-10% organic sales CAGR, primarily from lithium. Average EBITDA margins also targeted to reach 32-35% (vs. 29% 2017e), implying an EBITDA CAGR of 9%-15% (primarily from lithium, which improves margin mix)." (3/22/2017)

Some companies that are related to Albemarle Corporation include Celanese Corporation (CE), Eastman Chemical Company (EMN), Braskem S.A. (BAK), Westlake Chemical Corporation (WLK), Chemours Company (The) (CC), Olin Corporation (OLN), NewMarket Corporation (NEU), Methanex Corporation (MEOH), Ingevity Corp (NGVT), Quaker Chemical Corporation (KWR), Calgon Carbon Corporation (CCC), A. Schulman (SHLM), Innophos Holdings (IPHS), Koppers Holdings (KOP), CSW Industrials (CSWI), Westlake Chemical Partners LP (WLKP), Trecora Resources (TREC) and Enzymotec (ENZY).

Albemarle Corporation's management team includes the folowing people:

• Luther C. Kissam IV, Chairman, President and Chief Executive Officer
• Scott A. Tozier, Chief Financial Officer, Executive Vice President
• Karen G. Narwold, Executive Vice President, Chief Administrative Officer
• Matthew K. Juneau, Executive Vice President, Corporate Strategy
• Donald J. LaBauve Jr., Chief Accounting Officer, Vice President, Corporate Controller
• Jimmy W. Nokes, Lead Independent Director
• Laurie Brlas, Director
• William H. Hernandez, Independent Director
• Douglas L. Maine, Independent Director
• Jerry Kent Masters, Independent Director

Albemarle Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.29%), Franklin Resources Inc. (7.47%), BlackRock Inc. (7.23%), Jennison Associates LLC (5.80%), State Street Corp (5.44%) and FMR LLC (1.90%). Company insiders that own Albemarle Corporation stock include Donald J Jr Labauve, Douglas L Maine, John Sherman Jr, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle Corporation.

Albemarle Corporation's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Macquarie Group Ltd., Ameriprise Financial Inc., Columbus Circle Investors, Iridian Asset Management LLC CT, State Street Corp, BlackRock Inc. and WINTON GROUP Ltd. Company insiders that have sold Albemarle Corporation stock in the last year include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Insider Buying and Selling for Albemarle Corporation.

Albemarle Corporation's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Artisan Partners Limited Partnership, Jennison Associates LLC, TIAA CREF Investment Management LLC, JPMorgan Chase & Co., Federated Investors Inc. PA, Teachers Advisors LLC and Handelsbanken Fonder AB. View Insider Buying and Selling for Albemarle Corporation.

Shares of Albemarle Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Albemarle Corporation stock can currently be purchased for approximately $134.29.